Anti-inflammatory effect of polydeoxyribonucleotide on zoledronic acid-pretreated and lipopolysaccharide-stimulated RAW 264.7 cells

Bisphosphonates are generally used as therapeutic agents for bone diseases. However, previous reports on bisphosphonates-related osteonecrosis of the jaw (BRONJ) demonstrated that inflammation triggers and worsens the disease. Recently, polydeoxynucleotide (PDRN), an A(2A) receptor agonist, has been...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Exp Ther Med
Hlavní autoři: Han, Jin-Hee, Jung, Junho, Hwang, Lakkyong, Ko, Il-Gyu, Nam, Ok Hyung, Kim, Mi Sun, Lee, Jung-Woo, Choi, Byung-Joon, Lee, Deok-Won
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995037/
https://ncbi.nlm.nih.gov/pubmed/29896266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6186
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky